{"id":10305,"date":"2023-10-12T16:31:31","date_gmt":"2023-10-12T13:31:31","guid":{"rendered":"https:\/\/staging.grindeks.eu\/?page_id=10305"},"modified":"2025-08-22T07:56:09","modified_gmt":"2025-08-22T04:56:09","slug":"farmacijas-biomedicinas-un-medicinas-tehnologiju-kompetences-centrs","status":"publish","type":"page","link":"https:\/\/grindeks.com\/lv\/farmacijas-biomedicinas-un-medicinas-tehnologiju-kompetences-centrs\/","title":{"rendered":"Farm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centrs"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Farm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centrs<\/strong><\/p>\n\n\n\n

2023. gada 30. janv\u0101r\u012b SIA \u201cFarm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centrs\u201d (turpm\u0101k tekst\u0101 – Kompetences centrs) ar Centr\u0101lo finan\u0161u un l\u012bgumu a\u0123ent\u016bru (turpm\u0101k tekst\u0101 – A\u0123ent\u016bra) ir nosl\u0113gusi l\u012bgumu par projekta \u201cFarm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju kompetences centrs\u201d \u012bsteno\u0161anu, Projekta L\u012bgums Nr. 5.1.1.2.i.0\/1\/22\/A\/CFLA\/004 (turpm\u0101k tekst\u0101 \u2013 Projekts).<\/p>\n\n\n\n

Farm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centra m\u0113r\u0137is ir atbalst\u012bt vismaz 10 p\u0113t\u012bjumus atbilsto\u0161i diviem p\u0113tniec\u012bbas virzieniem:<\/p>\n\n\n\n

    \n
  1. Biofarm\u0101cija, biomedic\u012bna, medic\u012bnas tehnolo\u0123ijas, biotehnolo\u0123ija;\n
      \n
    1. Farm\u0101cija (ori\u0123in\u0101lz\u0101les un patentbr\u012bv\u0101s z\u0101les), dabas vielu z\u0101les, organisk\u0101 \u0137\u012bmija, kosm\u0113tika.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n\n\n\n

      Projekta ilgums: 02\/2023-06\/2026<\/p>\n\n\n\n

      Kop\u0113jais bud\u017eets: 6\u2019561\u2019147,15 EUR<\/p>\n\n\n\n

      ES finans\u0113jums: 3\u2019125\u2019000,00 EUR<\/p>\n\n\n\n

      Projekta ietvaros AS \u201cGrindeks\u201d realiz\u0113 sekojo\u0161us p\u0113tniec\u012bbas projektus:<\/p>\n\n\n\n

        \n
      1. P\u0113tniec\u012bbas projekts Nr.6 \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjumi\u201d (turpm\u0101k – P\u0113tniec\u012bbas projekts Nr.6);<\/li>\n\n\n\n
      2. P\u0113tniec\u012bbas projekts Nr.7 \u201cJaunu gatavo kombin\u0113to un monoproduktu sirds un asinsvadu sist\u0113mas slim\u012bbas grupas z\u0101\u013cu formu izstr\u0101de\u201d (turpm\u0101k – P\u0113tniec\u012bbas projekts Nr.7);<\/li>\n\n\n\n
      3. P\u0113tniec\u012bbas projekts Nr.8 \u201cJaunas patentbr\u012bvas akt\u012bv\u0101s farmaceitisk\u0101s vielas ieg\u016b\u0161anas metodes izstr\u0101de un tehnolo\u0123ijas aprob\u0101cija glaukomas \u0101rst\u0113\u0161anai\u201d (turpm\u0101k – P\u0113tniec\u012bbas projekts Nr.8).<\/li>\n\n\n\n
      4. P\u0113tniec\u012bbas projekts Nr.30  \u201cJaunu patentbr\u012bvu medikamentu farmaceitisko vielu izstr\u0101des un kl\u012bniskie p\u0113t\u012bjumi (turpm\u0101k – P\u0113tniec\u012bbas projekts Nr.30).<\/li>\n<\/ol>\n\n\n\n

        AKTIVIT\u0100\u0160U PROGRESS<\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 31.12.2023.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6 ietvaros izsludin\u0101tas un pabeigtas 2 iepirkuma proced\u016bras, nosl\u0113gti 2 l\u012bgumi un uzs\u0101kta 2 p\u0113t\u012bjumu realiz\u0101cija. 1 p\u0113t\u012bjumam sa\u0146emta at\u013cauja p\u0113t\u012bjuma uzs\u0101k\u0161anai.<\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7 ietvaros izsludin\u0101tas un pabeigtas 2 iepirkuma proced\u016bras, nosl\u0113gts 1 l\u012bgums un uzs\u0101kta 1 p\u0113t\u012bjuma realiz\u0101cija. Otram p\u0113t\u012bjumam norit l\u012bguma gatavo\u0161ana.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr.8 ietvaros izsludin\u0101ta un pabeigta iepirkuma proced\u016bra p\u0113t\u012bjuma veik\u0161anai, nosl\u0113gts l\u012bgums un uzs\u0101kta p\u0113t\u012bjuma realiz\u0113\u0161ana. P\u0113t\u012bjuma vajadz\u012bb\u0101m izsludin\u0101ta iepirkuma proced\u016bra rea\u0123entu ieg\u0101dei, nosl\u0113gti 2 iepirkuma l\u012bgumi un pabeigta rea\u0123entu pieg\u0101de abu nosl\u0113gto pieg\u0101\u017eu l\u012bgumu ietvaros.<\/p>\n\n\n\n

        Public\u0113ts: 29.12.2023<\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 31.03.2024.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6 ietvaros ir pabeigts 1 p\u0113t\u012bjums (sagatavota Gala atskaite), turpin\u0101s 1 p\u0113t\u012bjuma \u012bsteno\u0161ana un uzs\u0101kta 1 jauna p\u0113t\u012bjuma realiz\u0113\u0161ana.<\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7 ietvaros turpin\u0101s 1 p\u0113t\u012bjuma realiz\u0113\u0161ana, otrajam p\u0113t\u012bjumam norit l\u012bguma gatavo\u0161ana.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr.8 ietvaros turpin\u0101s darbs pie jaun\u0101s AFV ieg\u016b\u0161anas metodes izstr\u0101des, proti, pabeigts 2.starpposms (izv\u0113l\u0113t\u0101s sint\u0113zes sh\u0113mas aprob\u0101cija, izv\u0113loties piem\u0113rotas main\u012bgo faktoru (rea\u0123entu attiec\u012bbas, \u0161\u0137\u012bdin\u0101t\u0101ju, temperat\u016bras, reakcijas ilguma u.c. parametru) v\u0113rt\u012bbas un ieg\u016bstot visus starpproduktus vismaz 1 grama m\u0113rog\u0101, optimiz\u0101cijas pl\u0101na sast\u0101d\u012b\u0161ana un 2. starpposma atskaites iesnieg\u0161ana). P\u0113t\u012bjuma vajadz\u012bb\u0101m izsludin\u0101ta un pabeigta otra iepirkuma proced\u016bra rea\u0123entu un pal\u012bgmateri\u0101lu ieg\u0101dei, tiek gatavoti 2 iepirkuma l\u012bgumi.<\/p>\n\n\n\n

        Public\u0113ts: 28.03.2024<\/strong><\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 30.06.2024.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6 ietvaros turpin\u0101s 2 p\u0113t\u012bjumu \u012bsteno\u0161ana.<\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7 ietvaros turpin\u0101s 1 p\u0113t\u012bjuma realiz\u0113\u0161ana, otrajam p\u0113t\u012bjumam norit l\u012bguma gatavo\u0161ana.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr.8 ietvaros turpin\u0101s darbs pie jaun\u0101s AFV ieg\u016b\u0161anas metodes izstr\u0101des, proti, tiek realiz\u0113ta 3.starpposma aktivit\u0101te – Jaun\u0101s AFV sint\u0113zes metodes optimiz\u0101cija laboratorijas m\u0113rog\u0101.<\/p>\n\n\n\n

        Public\u0113ts: 30.06.2024<\/strong><\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 30.09.2024.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6 ietvaros turpin\u0101s 2 p\u0113t\u012bjumu \u012bsteno\u0161ana. Izsludin\u0101ts un pabeigts iepirkums par jauna p\u0113t\u012bjuma \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjums-4 (sirds un asinsvadu sist\u0113mas slim\u012bbu grup\u0101)\u201d \u012bsteno\u0161anu.<\/strong><\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7 ietvaros turpin\u0101s 1 p\u0113t\u012bjuma realiz\u0113\u0161ana, otrajam p\u0113t\u012bjumam nosl\u0113gts l\u012bgums un uzs\u0101kta p\u0113t\u012bjuma \u012bsteno\u0161ana.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr.8 ietvaros turpin\u0101s darbs pie jaun\u0101s AFV ieg\u016b\u0161anas metodes izstr\u0101des, proti, tiek pabeigta 3.starpposma aktivit\u0101te – Jaun\u0101s AFV sint\u0113zes metodes optimiz\u0101cija laboratorijas m\u0113rog\u0101. Sagatavota 3. starpposma atskaite. Parakst\u012bts Pie\u0146em\u0161anas \u2013 nodo\u0161anas akts par 3.starpposma darbiem.<\/p>\n\n\n\n

        4. P\u0113tniec\u012bbas projekta Nr. 30 ietvaros izsludin\u0101ts iepirkums un nosl\u0113gts l\u012bgums par p\u0113t\u012bjuma \u201cJaunas patentbr\u012bvas akt\u012bv\u0101s farmaceitisk\u0101s vielas Sugamadeks ieg\u016b\u0161anas metodes un tehnolo\u0123ijas izstr\u0101de un optimiz\u0101cija\u201d \u012bsteno\u0161anu. Uzs\u0101kta p\u0113t\u012bjuma 1.aktivit\u0101te \u201cLiterat\u016bras apskata sagatavo\u0161ana un piem\u0113rot\u0101ko ieg\u016b\u0161anas meto\u017eu teor\u0113tisk\u0101 izp\u0113te \u2013 rea\u0123entu un izejvielu pieejam\u012bba, sint\u0113zes tehnolo\u0123isko parametru atbilst\u012bbas r\u016bpniec\u012bbas iesp\u0113j\u0101m nov\u0113rt\u0113\u0161ana un selekcija. Piem\u0113rot\u0101k\u0101s sint\u0113zes sh\u0113mas izv\u0113le\u201d.<\/strong><\/p>\n\n\n\n

        Public\u0113ts: 30.09.2024<\/strong><\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 20.04.2025.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6 ietvaros jau ir \u012bstenoti divi p\u0113t\u012bjumi, un v\u0113l divu p\u0113t\u012bjumu \u012bsteno\u0161ana turpin\u0101s. Attiec\u012bb\u0101 uz patentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjumiem \u2013 p\u0113t\u012bjum\u0101 \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjums-3\u201d (centr\u0101l\u0101s nervu sist\u0113mas slim\u012bbu grup\u0101) un \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjums-4\u201d (sirds un asinsvadu sist\u0113mas slim\u012bbu grup\u0101) \u2013 ir pabeigti z\u0101\u013cu ievad\u012b\u0161anas un bioanal\u012btikas posmi.<\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7 ietvaros turpin\u0101s 1. p\u0113t\u012bjuma realiz\u0101cija un ir veiksm\u012bgi nosl\u0113gta 3. aktivit\u0101te \u201cGZF sast\u0101va izstr\u0101de\u201d. Turpin\u0101s ar\u012b 2. p\u0113t\u012bjuma realiz\u0101cija un ir veiksm\u012bgi nosl\u0113gta p\u0113t\u012bjuma 1. aktivit\u0101te \u201cReferences medikamenta izp\u0113te\u201d.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr.8 ietvaros realiz\u0113ts 1 p\u0113t\u012bjums par jaunas patentbr\u012bvas AFV sint\u0113zes metodes izstr\u0101di un tehnolo\u0123ijas m\u0113rogo\u0161anu jaunam prepar\u0101tam glaukomas slim\u012bbas \u0101rst\u0113\u0161anai. P\u0113tniec\u012bbas projekts tiek \u012bstenots k\u0101 starpnozaru p\u0113t\u012bjums sadarb\u012bb\u0101 ar iepirkuma proced\u016br\u0101 izv\u0113l\u0113tu zin\u0101tnisko instit\u016bciju \u2013 Latvijas Organisk\u0101s sint\u0113zes instit\u016btu. Atskaites period\u0101 tika realiz\u0113tas visas p\u0113t\u012bjuma aktivit\u0101tes \u00abJaun\u0101s AFV sint\u0113zes metodes tehnolo\u0123ijas m\u0113rogo\u0161ana un optimiz\u0101cija\u00bb, Veikta visu laboratorij\u0101 optimiz\u0113to AFV sint\u0113zes tehnolo\u0123ijas stadiju m\u0113rogo\u0161ana un optimiz\u0101cija. Sagatavota un apstiprin\u0101ta 4.starpposma p\u0113t\u012bjuma gala atskaite.<\/p>\n\n\n\n

        4. P\u0113tniec\u012bbas projekta Nr. 30 beidzies 1. p\u0113t\u012bjuma “Zin\u0101mo jaun\u0101s AFV ieg\u016b\u0161anas meto\u017eu izp\u0113te”, Sagatavota 1.starposma atskaite. Izp\u0113t\u012bta un apkopota literat\u016bra par zin\u0101maj\u0101m Sugamadeka ieg\u016b\u0161anas un att\u012br\u012b\u0161anas metod\u0113m.<\/p>\n\n\n\n

        Public\u0113ts: 27.05.2025<\/strong><\/p>\n\n\n\n

        Laika period\u0101 l\u012bdz 30.06.2025.:<\/p>\n\n\n\n

        1. P\u0113tniec\u012bbas projekta Nr. 6<\/strong> ietvaros p\u0101rskata period\u0101 tika veikti \u0161\u0101di darbi: P\u0113t\u012bjumam \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjums-3 (centr\u0101l\u0101s nervu sist\u0113mas slim\u012bbu grup\u0101)\u201d, sagatavota un apstiprin\u0101ta p\u0113t\u012bjuma gala atskaite.<\/p>\n\n\n\n

        P\u0113t\u012bjumam \u201cPatentbr\u012bvo z\u0101\u013cu bioekvivalences p\u0113t\u012bjums-4 (sirds un asinsvadu sist\u0113mas slim\u012bbu grup\u0101) \u201d, sagatavota un apstiprin\u0101ta p\u0113t\u012bjuma gala atskaite.<\/p>\n\n\n\n

        2. P\u0113tniec\u012bbas projekta Nr. 7<\/strong> ietvaros Norit \u00abAnal\u012btisko meto\u017eu izstr\u0101de un valid\u0101cija\u00bb, pabeigti \u0161\u0101di darbi: Pabeigta kvantitat\u012bv\u0101 satura, piemais\u012bjumu, \u0161\u0137\u012b\u0161anas meto\u017eu izstr\u0101de, notiek anal\u012btisko meto\u017eu da\u013c\u0113ja valid\u0101cija. Norit  \u00abGZF sast\u0101va izstr\u0101de\u00bb, pabeigti \u0161\u0101di darbi: Izstr\u0101d\u0101ta prototipa formul\u0101cija, izv\u0113rt\u0113ti kritiskie riski saist\u012bb\u0101 ar pal\u012bgvielu specifik\u0101ciju parametriem, prototipa formul\u0101cijas test\u0113\u0161ana, prototipa formul\u0101cijas atk\u0101rto\u0161anas s\u0113rijas ra\u017eo\u0161ana. P\u0113t\u012bjums virz\u0101s atbilsto\u0161i pl\u0101nam.<\/p>\n\n\n\n

        3. P\u0113tniec\u012bbas projekta Nr. 30<\/strong> ietvaros sagatavota 2. starpposma atskaite par izv\u0113l\u0113t\u0101s AFV ieg\u016b\u0161anas sh\u0113mas aprob\u0101ciju.  Saska\u0146ojot ar pas\u016bt\u012bt\u0101ju veikta sint\u0113zes sh\u0113mas aprob\u0101cija, izv\u0113loties piem\u0113rotas main\u012bgo faktoru (rea\u0123entu attiec\u012bbas, \u0161\u0137\u012bdin\u0101t\u0101ju, temperat\u016bras, reakcijas ilguma u.c. parametru) v\u0113rt\u012bbas un ieg\u016bti visi starpprodukti, sast\u0101d\u012bts optimiz\u0101cijas pl\u0101na un 2. starpposma atskaites iesnieg\u0161ana.<\/p>\n\n\n\n

        Kl\u012bniskie p\u0113t\u012bjumi-1 (centr\u0101l\u0101s nervu sist\u0113mas slim\u012bbu grup\u0101) pabeigta p\u0113t\u012bjuma dokument\u0101cijas sagatavo\u0161ana at\u013caujas sa\u0146em\u0161anai par p\u0113t\u012bjuma uzs\u0101k\u0161anu. Sagatavota un iesniegta p\u0113t\u012bjumam nepiecie\u0161am\u0101 dokument\u0101cija. Parakst\u012bts 1.starpposma pie\u0146em\u0161anas-nodo\u0161anas akts un   sagatavota p\u0113tnieka 1.starpposma atskaite.<\/p>\n\n\n\n

        4. P\u0113tniec\u012bbas projekta Nr.8<\/strong> P\u0113t\u012bjums sekm\u012bgi pabeigts.<\/p>\n\n\n\n

        Public\u0113ts: 21.08.2025<\/strong><\/p>\n\n\n\n

        <\/p>\n","protected":false},"excerpt":{"rendered":"

        Farm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centrs 2023. gada 30. janv\u0101r\u012b SIA \u201cFarm\u0101cijas, biomedic\u012bnas un medic\u012bnas tehnolo\u0123iju Kompetences centrs\u201d (turpm\u0101k tekst\u0101 – Kompetences centrs) ar Centr\u0101lo finan\u0161u…<\/p>\n","protected":false},"author":6,"featured_media":6601,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-10305","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/pages\/10305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=10305"}],"version-history":[{"count":6,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/pages\/10305\/revisions"}],"predecessor-version":[{"id":11483,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/pages\/10305\/revisions\/11483"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=10305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}